IQVIA HOLDINGS INC (QTS.DE) Stock Price, Forecast & Analysis
FRA:QTS • US46266C1053
QTS.DE Key Statistics, Chart & Performance
The current stock price of QTS.DE is 140.45 EUR. In the past month the price decreased by -32.9%.
QTS.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to QTS.DE.
QTS.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE. QTS.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
QTS.DE Financial Highlights
Over the last trailing twelve months QTS.DE reported a non-GAAP Earnings per Share(EPS) of 10.12. The EPS increased by 7.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.34% | ||
| ROA | 4.54% | ||
| ROE | 20.91% | ||
| Debt/Equity | 2.14 |
QTS.DE Forecast & Estimates
30 analysts have analysed QTS.DE and the average price target is 223.17 EUR. This implies a price increase of 58.9% is expected in the next year compared to the current price of 140.45.
For the next year, analysts expect an EPS growth of 9.67% and a revenue growth 6.51% for QTS.DE
QTS.DE Ownership
QTS.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 56S1 | SARTORIUS STEDIM BIOTECH | 33.91 | 17.612B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 33.61 | 17.198B | ||
| SRT3 | SARTORIUS AG-VORZUG | 38.56 | 17.095B | ||
| SRT | SARTORIUS AG | 31.5 | 13.838B | ||
| QIA | QIAGEN N.V. | 17.99 | 8.322B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.14 | 2.238B | ||
| EVT | EVOTEC SE | N/A | 2.06B | ||
| GXI | GERRESHEIMER AG | 6.21 | 661.096M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 16.52 | 250.381M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 159M |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About QTS.DE
Company Profile
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company Info
IQVIA HOLDINGS INC
2400 Ellis Road
Durham NORTH CAROLINA US
Employees: 88000
Phone: 19199982000
IQVIA HOLDINGS INC / QTS.DE FAQ
What does IQVIA HOLDINGS INC do?
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
What is the current price of QTS stock?
The current stock price of QTS.DE is 140.45 EUR. The price decreased by -0.99% in the last trading session.
Does QTS stock pay dividends?
QTS.DE does not pay a dividend.
How is the ChartMill rating for IQVIA HOLDINGS INC?
QTS.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is IQVIA HOLDINGS INC worth?
IQVIA HOLDINGS INC (QTS.DE) has a market capitalization of 23.82B EUR. This makes QTS.DE a Large Cap stock.
Who owns IQVIA HOLDINGS INC?
You can find the ownership structure of IQVIA HOLDINGS INC (QTS.DE) on the Ownership tab.